RhumbLine Advisers’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$79.6K Buy
+3,411
New +$79.6K ﹤0.01% 3592
2024
Q3
Sell
-852
Closed -$7.91K 4359
2024
Q2
$7.91K Sell
852
-1,285
-60% -$11.9K ﹤0.01% 4015
2024
Q1
$70K Buy
2,137
+88
+4% +$2.88K ﹤0.01% 3543
2023
Q4
$54.8K Sell
2,049
-60
-3% -$1.6K ﹤0.01% 3615
2023
Q3
$128K Sell
2,109
-20
-0.9% -$1.21K ﹤0.01% 3376
2023
Q2
$217K Sell
2,129
-2,171
-50% -$221K ﹤0.01% 3205
2023
Q1
$760K Buy
4,300
+234
+6% +$41.4K ﹤0.01% 2250
2022
Q4
$1.57M Buy
4,066
+29
+0.7% +$11.2K ﹤0.01% 1912
2022
Q3
$1.36M Buy
4,037
+247
+7% +$83.2K ﹤0.01% 1978
2022
Q2
$1.25M Buy
3,790
+180
+5% +$59.2K ﹤0.01% 2036
2022
Q1
$1.58M Buy
3,610
+2
+0.1% +$875 ﹤0.01% 1928
2021
Q4
$1.58M Sell
3,608
-29
-0.8% -$12.7K ﹤0.01% 2004
2021
Q3
$2.02M Sell
3,637
-497
-12% -$276K ﹤0.01% 1903
2021
Q2
$2.12M Buy
4,134
+2,646
+178% +$1.36M ﹤0.01% 1923
2021
Q1
$1.16M Sell
1,488
-96
-6% -$75K ﹤0.01% 2136
2020
Q4
$863K Buy
1,584
+60
+4% +$32.7K ﹤0.01% 2207
2020
Q3
$698K Sell
1,524
-230
-13% -$105K ﹤0.01% 2139
2020
Q2
$1.08M Buy
1,754
+121
+7% +$74.5K ﹤0.01% 2011
2020
Q1
$777K Sell
1,633
-66
-4% -$31.4K ﹤0.01% 1991
2019
Q4
$986K Buy
1,699
+137
+9% +$79.5K ﹤0.01% 2094
2019
Q3
$1.03M Buy
1,562
+145
+10% +$95.4K ﹤0.01% 2025
2019
Q2
$1.1M Buy
1,417
+124
+10% +$96K ﹤0.01% 2023
2019
Q1
$913K Buy
1,293
+69
+6% +$48.7K ﹤0.01% 2080
2018
Q4
$573K Buy
1,224
+444
+57% +$208K ﹤0.01% 2230
2018
Q3
$673K Buy
780
+39
+5% +$33.7K ﹤0.01% 2168
2018
Q2
$511K Buy
741
+38
+5% +$26.2K ﹤0.01% 2305
2018
Q1
$313K Sell
703
-22
-3% -$9.8K ﹤0.01% 2413
2017
Q4
$320K Sell
725
-136
-16% -$60K ﹤0.01% 2439
2017
Q3
$424K Buy
861
+13
+2% +$6.4K ﹤0.01% 2393
2017
Q2
$470K Buy
848
+121
+17% +$67.1K ﹤0.01% 2335
2017
Q1
$481K Buy
727
+22
+3% +$14.6K ﹤0.01% 2269
2016
Q4
$236K Buy
705
+27
+4% +$9.04K ﹤0.01% 2605
2016
Q3
$204K Sell
678
-239
-26% -$71.9K ﹤0.01% 2669
2016
Q2
$159K Buy
917
+388
+73% +$67.3K ﹤0.01% 2823
2016
Q1
$118K Buy
529
+10
+2% +$2.23K ﹤0.01% 2867
2015
Q4
$315K Buy
519
+69
+15% +$41.9K ﹤0.01% 2550
2015
Q3
$232K Buy
450
+56
+14% +$28.9K ﹤0.01% 2701
2015
Q2
$172K Buy
+394
New +$172K ﹤0.01% 2932